Related Experiment Video
Updated: Jun 28, 2025

Author Spotlight: Unveiling the Role of SNF2L in Replication Fork Stability and Genome Duplication
Published on: August 23, 2024
UFL1 triggers replication fork degradation by MRE11 in BRCA1/2-deficient cells
Tian Tian1,2, Junliang Chen3, Huacun Zhao4
1Zhejiang Key Laboratory of Geriatrics and Geriatrics Institute of Zhejiang Province, Affiliated Zhejiang Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Abstract:
The stabilization of stalled forks has emerged as a crucial mechanism driving resistance to poly(ADP-ribose) polymerase (PARP) inhibitors in BRCA1/2-deficient tumors. Here, we identify UFL1, a UFM1-specific E3 ligase, as a pivotal regulator of fork stability and the response to PARP inhibitors in BRCA1/2-deficient cells. On replication stress, UFL1 localizes to stalled forks and catalyzes the UFMylation of PTIP, a component of the MLL3/4 methyltransferase complex, specifically at lysine 148. This modification facilitates the assembly of the PTIP-MLL3/4 complex, resulting in the enrichment of H3K4me1 and H3K4me3 at stalled forks and subsequent recruitment of the MRE11 nuclease. Consequently, loss of UFL1, disruption of PTIP UFMylation or overexpression of the UFM1 protease UFSP2 protects nascent DNA strands from extensive degradation and confers resistance to PARP inhibitors in BRCA1/2-deficient cells. These findings provide mechanistic insights into the processes underlying fork instability in BRCA1/2-deficient cells and offer potential therapeutic avenues for the treatment of BRCA1/2-deficient tumors.
Insights
UFL1 stabilizes stalled replication forks in BRCA1/2-deficient tumors, conferring resistance to PARP inhibitors. Its loss or disruption of PTIP UFMylation protects DNA and enhances treatment resistance.
Area of Science:
- Molecular Biology
- Cancer Biology
- Genetics
Background:
- Replication fork stability is crucial for preventing genomic instability in cancer.
- Resistance to poly(ADP-ribose) polymerase (PARP) inhibitors in BRCA1/2-deficient tumors is often mediated by mechanisms that stabilize stalled replication forks.
- Understanding these resistance mechanisms is vital for developing effective cancer therapies.
Purpose of the Study:
- To identify key regulators of replication fork stability in the context of PARP inhibitor resistance.
- To elucidate the molecular mechanisms by which UFL1 influences fork stability and PARP inhibitor response.
- To explore potential therapeutic targets for overcoming PARP inhibitor resistance in BRCA1/2-deficient cancers.
Main Methods:
- Utilized cell-based assays to study replication fork dynamics under replication stress.
- Employed biochemical techniques including immunoprecipitation and Western blotting to investigate protein interactions and modifications.
- Analyzed the role of UFL1, UFMylation, and PTIP modification in regulating DNA strand integrity and PARP inhibitor sensitivity.
Main Results:
- Identified UFL1, a UFM1-specific E3 ligase, as a critical regulator of fork stability in BRCA1/2-deficient cells.
- Demonstrated that UFL1 catalyzes PTIP UFMylation at stalled forks, promoting MLL3/4 complex assembly and H3K4 methylation.
- Showed that loss of UFL1, impaired PTIP UFMylation, or UFSP2 overexpression protects nascent DNA from degradation and confers resistance to PARP inhibitors.
Conclusions:
- UFL1-mediated PTIP UFMylation is a novel mechanism that stabilizes stalled replication forks and drives PARP inhibitor resistance in BRCA1/2-deficient tumors.
- Targeting the UFL1-PTIP axis could offer a strategy to sensitize BRCA1/2-deficient tumors to PARP inhibitors.
- These findings provide critical mechanistic insights into therapeutic resistance and suggest new avenues for cancer treatment.
Related Concept Videos
Restarting Stalled Replication Forks
The DNA Replication Fork
Homologous Recombination
Long-patch Base Excision Repair
Nucleotide Excision Repair
DNA Damage can Stall the Cell Cycle

